Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ITGB3 | P05106 | 20/20 | 0.57 |
| ▸ | ITGA2B | P08514 | 8/20 | 0.57 |
| ▸ | ITGAV | P06756 | 16/20 | 0.53 |
| ▸ | ITGB5 | P18084 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29262108 | 1.00 | ITGB3 (0.57) | ITGB3ITGA2BITGAVITGB5 | |
| SCHEMBL13344587 | 0.89 | ITGB3 (0.58) | ITGB3ITGA2BITGAVITGB5 | |
| SCHEMBL5755977 | 0.88 | ITGB3 (0.60) | ITGB3ITGA2BITGAVITGB5 | |
| SCHEMBL13344620 | 0.85 | ITGB3 (0.56) | ITGB3ITGA2BITGAVITGB5 | |
| SCHEMBL13369222 | 0.84 | ITGB3 (0.52) | ITGB3ITGA2BITGAV | |
| SCHEMBL13344598 | 0.84 | ITGB3 (0.57) | ITGB3ITGA2BITGAV | |
| SCHEMBL3536943 | 0.83 | ITGB3 (0.53) | ITGB3ITGA2BITGAV | |
| SCHEMBL13344616 | 0.82 | ITGB3 (0.54) | ITGB3ITGA2BITGAVITGB5 | |
| SCHEMBL13344624 | 0.82 | ITGB3 (0.56) | ITGB3ITGA2BITGAV | |
| SCHEMBL13369312 | 0.81 | ITGB3 (0.49) | ITGB3ITGA2BITGAV |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114901086-B | Tobacco treatment | 英美烟草(投资)有限公司 | 2024-05-31 | — | — | CN | disclosed |
| US-7718673-B2 | Isonipecotamides for the treatment of integrin-mediated disorders | ORTHO-MCNEIL PHARMACEUTICAL, INC. (US) | 2010-05-18 | — | — | US | disclosed |
| US-7718673-B2 | Isonipecotamides for the treatment of integrin-mediated disorders | ORTHO-MCNEIL PHARMACEUTICAL, INC. (US) | 2010-05-18 | — | — | US | disclosed |